The manufacture of inhalers had to evolve in response to the increased prevalence of respiratory diseases.
LONDON, UK, June 28, 2022 /EINPresswire.com/ — The Global inhaler market size reached USD 19,445.4 million in 2021 and is expected to reach USD 26,110.01 million by 2028, growing at a CAGR of 4.3% during the forecast period. As respiratory dysfunction is one of the most common health problems in the world, the respiratory care market has a strong presence in the medical profession. Growing awareness of certain respiratory diseases, including COPD and asthma, substantial increase in the number of elderly patients (the majority of whom seek relief from at least one form of respiratory disease), growing awareness of certain respiratory conditions, such as obstructive sleep apnea and an overall increase in demand for better patient care are all growth drivers. For millions of patients, respiratory inhalers have proven lifesaving.
View full report: https://precisionbusinessinsights.com/market-reports/inhalers-market/
The Inhaler Market – Growth Factors
The respiratory inhalers market is expected to grow due to an increase in the incidence of respiratory disorders including asthma or chronic obstructive pulmonary disease (COPD) globally. According to the World Health Organization (WHO), asthma claimed the lives of more than 384,000 people in 2015. This graph clearly shows an increase in asthma cases, which will force manufacturers of respiratory inhalers to increase their production rates to meet increased demand. . Apart from this, the increasing levels of air pollution in the world due to wildfires, the increase in the number of cars and the increase in the number of factories are expected to help the respiratory inhalers market expansion. Recent approvals of numerous respiratory inhalers are expected to boost the market.
The Inhaler Market – Segmentation
The global inhalers market on the basis of device type, the market is categorized into dry powder inhaler, metered dose inhaler, nebulizer is further segmented into ultrasonic, tablet, mesh. Based on the type of inhaler, the market is divided into rescue, preventative and long-acting bronchodilators. Based on application, the market is divided into chronic obstructive pulmonary disease, asthma, cystic fibrosis, and pulmonary arterial hypertension. On the basis of end-user, the market is categorized into home care, hospitals, and clinics.
The Inhaler Market Trend:
The market is expected to grow owing to the increase in the number of smokers and the prevalence of lung disorders.
Restraining Factor of Inhalers Market:
During the projected period, the increasing use of alternative therapies, including oral medications and subcutaneous injections, which are provided free of charge in several public hospitals and some other non-profit organizations, is expected to hamper the expansion of the market.
The Inhaler Market – Regional Analysis
Due to the huge increase in asthma cases and the existence of established competitors in the region, North America now retains the largest market and is expected to continue to do so in the coming years. Analysts predict significant demand for inhalers in Asia-Pacific over the next few years, driven by a growing elderly population, increased awareness of respiratory disorders, and rising healthcare costs.
Request a sample report: https://precisionbusinessinsights.com/request-sample?product_id=38138
Impacts of the COVID-19 pandemic on the global inhaler market
The rising rate of corona patients developing a variety of respiratory issues has fueled the market demand. Additionally, there was an unexpected increase in patient visits as well as hospital admissions due to respiratory issues. Additionally, a substantial burden of disease has emerged due to an increasing number of COVID-19 patients having side effects such as COPD. The demand for inhalers has increased accordingly.
Smart Inhalers Market by Product Type (Inhalers, Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers), by Application (COPD and Asthma), by Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies) and Geography
Respiratory Inhalers Market: By Product Type (MDI, Nebulizer, Dry Powder Inhaler), By Technology (Manually Operated Inhalers, Digitally Operated Inhalers), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD) , pulmonary arterial hypertension, others), by distribution channel (hospital pharmacies, retail pharmacies, online pharmacies) and geography
Cystic Fibrosis (CF) Diagnostics Market By Test Type (Prenatal Test, Carriage Test, Sweat Tests, CFTR-Related Metabolic Syndrome (CRMS), Newborn Screening, Prenatal Screening), By Product Type (Pregnancy Testing Kits, diagnosis, reagents and others) end user (Hospitals and Diagnostic Centers) and Geography
Cystic Fibrosis (CF) Treatment Market: By Product Type (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators), By Route of Administration (Oral and Inhaled) and Geography
Pulmonary Embolism Devices Market: By Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter Directed Thrombolysis Devices), By End User (Hospitals, Diagnostic Centers, Centers outpatient surgery) by geography